Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$534M |
| 2 |
Amazon
AMZN
|
+$399M |
| 3 |
Abbott
ABT
|
+$381M |
| 4 |
Adobe
ADBE
|
+$353M |
| 5 |
Oracle
ORCL
|
+$261M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$407M |
| 2 |
Bank of America
BAC
|
+$368M |
| 3 |
TE Connectivity
TEL
|
+$366M |
| 4 |
Goldman Sachs
GS
|
+$302M |
| 5 |
Atlassian
TEAM
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.57% |
| 2 | Healthcare | 19.51% |
| 3 | Consumer Discretionary | 9.79% |
| 4 | Industrials | 9.79% |
| 5 | Financials | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Penumbra
PEN
$12.6B
| $64.7M | 0.04% |
257,325
-13,158
| -5% | -$2.91M |
|
327
MSC Industrial Direct
MSM
$6.83B
| $64.6M | 0.04% |
637,807
-267,190
| -30% | -$26.4M |
|
328
Roper Technologies
ROP
$39.6B
| $64.3M | 0.04% |
117,919
-8,226
| -7% | -$4.24M |
|
329
Cardinal Health
CAH
$54.4B
| $63.5M | 0.04% |
630,184
-88,764
| -12% | -$8.81M |
|
330
Wendy's
WEN
$1.46B
| $63.4M | 0.04% |
3,252,919
+18,543
| +0.6% | +$357K |
|
331
Frontdoor
FTDR
$5.17B
| $63.1M | 0.04% |
1,791,785
-884,126
| -33% | -$29.4M |
|
332
Revolution Medicines
RVMD
$38.5B
| $63.1M | 0.04% |
2,199,480
-41,259
| -2% | -$991K |
|
333
Structure Therapeutics
GPCR
$3.38B
| $62.8M | 0.04% |
1,544,416
-546,907
| -26% | -$31.3M |
|
334
4D Molecular Therapeutics
FDMT
$499M
| $62.7M | 0.04% |
3,093,296
+346,961
| +13% | +$4.56M |
|
|
CRGX
335
DELISTED
CARGO Therapeutics
CRGX
| $62.6M | 0.04% |
+2,702,731
| New | +$45.8M |
|
336
Bruker
BRKR
$9.61B
| $61.7M | 0.04% |
839,639
-1,863
| -0.2% | -$119K |
|
337
Mirum Pharmaceuticals
MIRM
$6.72B
| $60.9M | 0.04% |
2,062,551
+138,791
| +7% | +$4.2M |
|
338
Descartes Systems
DSGX
$6.71B
| $60.3M | 0.04% |
714,203
+2,327
| +0.3% | +$181K |
|
339
IPG Photonics
IPGP
$3.47B
| $59.8M | 0.04% |
550,622
-149,208
| -21% | -$14.5M |
|
|
CSW
340
CSW Industrials
CSW
$4.61B
| $59.5M | 0.04% |
287,074
-15,397
| -5% | -$2.79M |
|
341
Nordson
NDSN
$16.6B
| $58.5M | 0.03% |
221,539
-113,761
| -34% | -$26.4M |
|
342
PepsiCo
PEP
$197B
| $58.1M | 0.03% |
341,824
-16,921
| -5% | -$2.81M |
|
343
Entegris
ENTG
$17.2B
| $57.9M | 0.03% |
483,297
-81,587
| -14% | -$8.28M |
|
344
GE HealthCare
GEHC
$32.5B
| $57.6M | 0.03% |
744,878
-148,445
| -17% | -$10.4M |
|
345
Commercial Metals
CMC
$7.65B
| $56.7M | 0.03% |
1,133,953
+4,050
| +0.4% | +$185K |
|
346
Alcon
ALC
$34B
| $56.4M | 0.03% |
722,935
-79,605
| -10% | -$5.88M |
|
347
Entergy
ETR
$51.5B
| $56.3M | 0.03% |
1,112,540
+22,848
| +2% | +$1.12M |
|
348
Black Hills Corp
BKH
$5.68B
| $55.8M | 0.03% |
1,034,591
-64,762
| -6% | -$3.32M |
|
349
NRG Energy
NRG
$26.6B
| $55.7M | 0.03% |
1,076,686
-5,653
| -0.5% | -$256K |
|
|
P
350
Everpure Inc
P
$23.8B
| $55.5M | 0.03% |
1,557,443
+572,038
| +58% | +$20.1M |
|
Similar funds
Janus Henderson Group's Q4 2023 Portfolio in Review
As of Q4 2023, Janus Henderson Group held 2,657 positions worth $168B, up 9.8% from $153B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Janus Henderson Group's Q4 2023 filing shows 98 new, 642 increased, 1,760 reduced and 111 closed positions. Its largest new stake was Veralto: 2,881,576 shares worth $237M. The largest sale was Sherwin-Williams, an estimated $407M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q4 2023 buy was Veralto: 2,881,576 shares worth $237M.
- Janus Henderson Group added most to Eli Lilly in Q4 2023, an estimated $534M increase.
- Janus Henderson Group's biggest Q4 2023 reduction was Sherwin-Williams, cutting an estimated $407M.
- Janus Henderson Group fully exited National Instruments Corp in Q4 2023, selling an estimated $243M.
- Janus Henderson Group's ten largest holdings make up 27% of its $168B portfolio in Q4 2023.
- Janus Henderson Group opened 98 new positions and closed 111 in Q4 2023.
- Janus Henderson Group's portfolio value rose 9.8% quarter-over-quarter to $168B.
Based on Janus Henderson Group's 13F filing for Q4 2023, filed 14 Feb 2024.